Clinical Trial Update: The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and immune response to an acellular pertussis vaccine in bone marrow transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Acellular pertussis vaccine (acellular pertussis vaccine)

Snippet

Sponsor: Queen Elizabeth II Health Sciences Centre | Conditions: Pertussis | Phase 4 | Status: UNKNOWN